ANTHRACYCLINE-DERIVED CHEMOTHERAPEUTICS IN APOPTOSIS AND FREE-RADICALCYTOTOXICITY (REVIEW)

Citation
I. Muller et al., ANTHRACYCLINE-DERIVED CHEMOTHERAPEUTICS IN APOPTOSIS AND FREE-RADICALCYTOTOXICITY (REVIEW), INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(2), 1998, pp. 491-494
Citations number
42
Categorie Soggetti
Medicine, Research & Experimental
ISSN journal
11073756
Volume
1
Issue
2
Year of publication
1998
Pages
491 - 494
Database
ISI
SICI code
1107-3756(1998)1:2<491:ACIAAF>2.0.ZU;2-0
Abstract
Anthracycline-derivatives are frequently used chemotherapeutics in tre atment of numerous human malignancies. Anthracyclines are known for th eir complex cytotoxic mechanism involving i) inhibition of enzymes suc h as topoisomerase II, RNA polymerase, cytochrome c oxidase and others ; ii) intercalation into DNA; iii) chelation of iron and generation of reactive oxygen species (ROS); iv) induction of apoptosis. Here, mech anistic aspects for successful cytostasis and for side effects, e.g. c ardiomyopathy, are discussed. We emphasize recent developments in anth racycline-mediated apoptosis and focus on a well known representative, doxorubicin (adriamycin, adriblastin). We reflect on the role of oxid ative stress and interactions with intracellular signaling pathways.